Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Triple-negative breast cancer: understanding Wnt signaling in drug resistance
Parnaz Merikhian, Mohammad Reza Eisavand, Leila Farahmand
Cancer Cell International (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 72

Showing 1-25 of 72 citing articles:

Targeted Therapy and Mechanisms of Drug Resistance in Breast Cancer
Briana Kinnel, Santosh Kumar Singh, Gabriela Oprea‐Ilies, et al.
Cancers (2023) Vol. 15, Iss. 4, pp. 1320-1320
Open Access | Times Cited: 75
Therapeutic progress and challenges for triple negative breast cancer: targeted therapy and immunotherapy
Ruoning Yang, Yueyi Li, Hang Wang, et al.
Molecular Biomedicine (2022) Vol. 3, Iss. 1
Open Access | Times Cited: 74
Recent advancements in nanoconstructs for the theranostics applications for triple negative breast cancer
Ashutosh Gupta, Kumar Nishchaya, Moumita Saha, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 93, pp. 105401-105401
Open Access | Times Cited: 19
Molecular Targets of Triple-Negative Breast Cancer: Where Do We Stand?
Emma E. Newton, Lauren Mueller, Scout Treadwell, et al.
Cancers (2022) Vol. 14, Iss. 3, pp. 482-482
Open Access | Times Cited: 41
On a sugar high: Role of O-GlcNAcylation in cancer
Giang Lê Minh, Emily M. Esquea, Riley G. Young, et al.
Journal of Biological Chemistry (2023) Vol. 299, Iss. 11, pp. 105344-105344
Open Access | Times Cited: 32
Triple-Negative Breast Cancer Progression and Drug Resistance in the Context of Epithelial–Mesenchymal Transition
Ewa Błaszczak, Paulina Miziak, Adrian Odrzywolski, et al.
Cancers (2025) Vol. 17, Iss. 2, pp. 228-228
Open Access | Times Cited: 1
Tumor dormancy and relapse: understanding the molecular mechanisms of cancer recurrence
Muhammad Tufail, Canhua Jiang, Ning Li
Military Medical Research (2025) Vol. 12, Iss. 1
Open Access | Times Cited: 1
Challenges for Triple Negative Breast Cancer Treatment: Defeating Heterogeneity and Cancer Stemness
Rinad Mahmoud, Paloma Ordóñez‐Morán, Cinzia Allegrucci
Cancers (2022) Vol. 14, Iss. 17, pp. 4280-4280
Open Access | Times Cited: 33
Luminous MoS2 nanosheet-based electrochemiluminescence biosensor with biomimetic vesicle for miRNA-210 detection
Jingwei Shi, Zhang Yang, Peilin Wang, et al.
Talanta (2021) Vol. 237, pp. 122969-122969
Closed Access | Times Cited: 34
PRMT1 Regulates EGFR and Wnt Signaling Pathways and Is a Promising Target for Combinatorial Treatment of Breast Cancer
Samyuktha Suresh, S. Huard, Amélie Brisson, et al.
Cancers (2022) Vol. 14, Iss. 2, pp. 306-306
Open Access | Times Cited: 25
FZD7-Targeted Nanoparticles to Enhance Doxorubicin Treatment of Triple-Negative Breast Cancer
Elise C. Hoover, Olivia M. Ruggiero, Rachel N. Swingler, et al.
ACS Omega (2024) Vol. 9, Iss. 12, pp. 14323-14335
Open Access | Times Cited: 5
Exploratory drug discovery in breast cancer patients: A multimodal deep learning approach to identify novel drug candidates targeting RTK signaling
Anush Karampuri, Sunitha Kundur, Perugu Shyam
Computers in Biology and Medicine (2024) Vol. 174, pp. 108433-108433
Closed Access | Times Cited: 5
Piperine enhances doxorubicin sensitivity in triple-negative breast cancer by targeting the PI3K/Akt/mTOR pathway and cancer stem cells
Andrew Hakeem, Dina M. El‐Kersh, Olfat Hammam, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 5
Investigating the role of exosomal long non-coding RNAs in drug resistance within female reproductive system cancers
Nooshafarin Shirani, N. Abdi, Matin Chehelgerdi, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 13
Open Access
Wnt/β-catenin signalling pathway in breast cancer cells and its effect on reversing tumour drug resistance by alkaloids extracted from traditional Chinese medicine
Xinlei Wu, Shen-Guo Lin, Yi-Wen Mao, et al.
Expert Reviews in Molecular Medicine (2023) Vol. 25
Closed Access | Times Cited: 11
Antibody and siRNA Nanocarriers to Suppress Wnt Signaling, Tumor Growth, and Lung Metastasis in Triple‐Negative Breast Cancer
Megan N. Dang, Sejal Suri, Kejian Li, et al.
Advanced Therapeutics (2024) Vol. 7, Iss. 6
Closed Access | Times Cited: 4
Antibody/siRNA Nanocarriers Against Wnt Signaling Suppress Oncogenic and Stem‐Like Behavior in Triple‐Negative Breast Cancer Cells
Elise C. Hoover, Emily S. Day
Journal of Biomedical Materials Research Part A (2025) Vol. 113, Iss. 1
Closed Access
Breast cancer stem cell: Role in pathogenesis
Riya Sharma, Vikas Tiwari, Seema Seema, et al.
Elsevier eBooks (2025), pp. 207-224
Closed Access
Integrating multi-omics data of Triple-Negative Breast Cancer to explore the role of Kynurenine pathway and KYNU as a therapeutic target
Min Lin, J. Zhou, Jun Xiao, et al.
Biochemical and Biophysical Research Communications (2025) Vol. 756, pp. 151569-151569
Closed Access
Wnt signaling in cancer: from biomarkers to targeted therapies and clinical translation
Muhammad Tufail, Canhua Jiang, Ning Li
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access
Understanding the Molecular Mechanisms of SORBS2 in TNBC Lung Metastasis
Guizhen Zhao, Chunzheng Li, Wan Liu, et al.
Biochemical and Biophysical Research Communications (2025) Vol. 762, pp. 151762-151762
Closed Access
Recent Clinical Advances on Long Non-Coding RNAs in Triple-Negative Breast Cancer
Desh Deepak Singh, Hae‐Jeung Lee, Dharmendra Kumar Yadav
Cells (2023) Vol. 12, Iss. 4, pp. 674-674
Open Access | Times Cited: 9
Systems approach for congruence and selection of cancer models towards precision medicine
Jian Zou, Osama Shiraz Shah, Yu‐Chiao Chiu, et al.
PLoS Computational Biology (2024) Vol. 20, Iss. 1, pp. e1011754-e1011754
Open Access | Times Cited: 3
Sphingomyelin synthase 2 promotes the stemness of breast cancer cells via modulating NF-κB signaling pathway
Haizhan Feng, Yahui Dong, Kunling Chen, et al.
Journal of Cancer Research and Clinical Oncology (2024) Vol. 150, Iss. 2
Open Access | Times Cited: 3
From dietary lignans to cancer therapy: Integrative systems analysis of enterolactone's molecular targets and signaling pathways in combatting cancer stem cells in triple-negative breast cancer
Akanksha Mahajan, Nidhi Sharma, Amrita Ulhe, et al.
Food Bioscience (2024) Vol. 58, pp. 103732-103732
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top